Key result
In CRT recipients, a history of atrial fibrillation combined with biventricular pacing ≤98% during the first year was associated with a higher risk of death or heart transplantation compared to patients without atrial fibrillation.
Why the study?
In patients treated with CRT, AF is linked to unfavorable outcomes and can reduce biventricular pacing, an established determinant of CRT success.
Does achieving >98% biventricular pacing improve long-term survival in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy?
Cohort (n=379)
No
Does achieving >98% biventricular pacing improve long-term survival in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy?
Answers are grounded in this paper and cite their sources.
In heart failure patients receiving CRT, a history of atrial fibrillation combined with biventricular pacing ≤98% independently predicts poor long-term outcomes, emphasizing the critical need to achieve >98% biventricular pacing to maximize CRT benefits.
BACKGROUND: In patients with cardiac resynchronization therapy (CRT), atrial fibrillation (AF) is associated with an unfavorable outcome and may cause loss of biventricular pacing (BivP). An effective delivery of BivP of more than 98% of all ventricular beats has been shown to be a major determinant of CRT-success. METHODS: At a Swedish tertiary referral center, data was retrospectively obtained from patient registers, medical records and preoperative electrocardiograms. Data regarding AF and BivP during the first year of follow-up was assessed from CRT-device interrogations. No intra-cardiac electrograms were studied. Kaplan-Meier curves and Cox-regression analyses adjusted for age, etiology of heart failure, left ventricular ejection fraction, left bundle branch block and NYHA class were performed to assess the impact of AF and BivP on the risk of death or heart transplantation (HTx) at 10-years of follow-up. RESULTS: Preoperative AF-history was found in 54% of the 379 included patients and was associated with, but did not independently predict death or HTx. The one-year incidence of new device-detected AF was 22% but not associated with poorer prognosis. At one-year, AF-history and BivP≤98%, was associated with a higher risk of death or HTx compared to patients without AF (HR 1.9, 95%CI 1.2-3.0, p = 0.005) whereas AF and BivP> 98% was not (HR 1.4, 95%CI 0.9-2.3, p = 0.14). CONCLUSIONS: In CRT-recipients, AF-history is common and associated with poor outcome. AF-history does not independently predict mortality and is probably only a marker of a more severe underlying disease. BivP≤98% during first-year of CRT-treatment independently predicts poor outcome thus further supporting the use of 98% threshold of BivP, which should be attained to maximize the benefits of CRT.
No takes yet. Share an insight, caveat, or question.
Jacobsson et al. (2019) conducted a cohort in Heart failure (n=379). Atrial fibrillation history and biventricular pacing ≤98% vs. No atrial fibrillation was evaluated on Death from any cause or heart transplantation (HR 1.9, 95% CI 1.2-3.0, p=0.005). In CRT recipients, a history of atrial fibrillation combined with biventricular pacing ≤98% during the first year was associated with a higher risk of death or heart transplantation compared to patients without atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: